Bluestar Adisseo Company engages in the research, development, production, and sale of animal nutrient additives worldwide. The company offers Rhodimet, a methionine solution for animals, including Rhodimet AT88 and Rhodimet NP99; Smartamine and MetaSmart for proper balance of amino acid; AdiSodium, a feed material for monogastric and ruminants; Microvit, a vitamin additives in animal nutrition; Krave AP stimulate appetite and feed intake during lactation; Optisweet, a feed sweetener to stimulate early feed intake; Gusti Plus improves the palatability of feeds and supplements; Maxamore provides feed with aroma and uniform taste; and Delistart, a combination of flavorings, appetizing substances, and sweeteners for piglets and calves. It also provides Rovabio Excel, a feed additive containing a combination of 19 active enzymes; Rovabio Advance, a feedase to improve the digestibility of all feed nutrients; Rovabio Advance PHY, multi-enzymatic solution for overall feed digestibility; Rovabio PhyPlus, a phytase solution; FRA LeciMax, a feed additive that improves FCR and ADWG; Selisseo, a hydroxy- selenomethionine for stress resistance; Apex 5 enhances botanical booster; Alterion, a probiotic solution; Adimix Precision, precision delivery coated sodium butyrate; FRA Butyrin, for healthy intestinal environment comprising FRA Butyrin Hybrid and Ultra; FRA C12, a solution to reduce the usage of antibiotic growth promotors in animal production; and FRA Gut Balance for pathogen control. In addition, the company offers Unike Plus, Unike, Toxy-Nil for mycotoxin management; Oxy-Nil, an antioxidant program; and aquaculture specialties products, including Aqualyso, Lipogest, Sanacore GM, Bacti-Nil Aqua, and Apex Branchia. Further, it provides services, including PNE, Nestor, Adict, DIM, Feedase Predictor, Milkpay, and Milk$mart. The company was founded in 1939 and is based in Beijing, China. Bluestar Adisseo Company is a subsidiary of China National Bluestar (Group) Co., Ltd.
Metrics to compare | 600299 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600299PeersSector | |
---|---|---|---|---|
P/E Ratio | 18.8x | 39.1x | 0.1x | |
PEG Ratio | 0.17 | 0.16 | 0.00 | |
Price/Book | 1.5x | 2.0x | 1.6x | |
Price / LTM Sales | 1.5x | 1.6x | 1.4x | |
Upside (Analyst Target) | 19.8% | 20.5% | 20.3% | |
Fair Value Upside | Unlock | 5.3% | −0.3% | Unlock |